Denka Co (4061) Price & Analysis

Compare

4 Followers

4061 Stock Chart & Stats

¥2747.50

-¥46.00(-2.04%)

At close: Jan 08 4:00 PM EST

¥2747.50

-¥46.00(-2.04%)

Day’s Range― - ―

52-Week Range¥1,744.00 - ¥3,750.00

Previous CloseN/A

Volume515.40K

Average Volume (3M)424.75K

Market Cap

¥296.19B

Enterprise Value¥487.96B

Total Cash (Recent Filing)¥42.55B

Total Debt (Recent Filing)¥222.64B

Price to Earnings (P/E)36.2

Beta0.91

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield3.71%

Share Statistics

EPS (TTM)N/A

Shares Outstanding88,555,840

10 Day Avg. Volume419,400

30 Day Avg. Volume424,753

Financial Highlights & Ratios

PEG Ratio0.07

Price to Book (P/B)0.62

Price to Sales (P/S)0.46

P/FCF Ratio-4.59

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Diversified End-market ExposureDenka's product mix spans electronics, mobility, construction, packaging and healthcare. This diversified B2B exposure reduces reliance on any single cyclical end market, providing multiple structural demand channels and helping stabilize revenues and investment priorities over a multi-month horizon.

Manageable Balance Sheet LeverageA debt-to-equity of 0.74 and 45.2% equity ratio indicate a capital structure with room to absorb shocks and fund strategic initiatives. This level of leverage supports multi-month financial flexibility for capex, working capital, or restructuring without forcing urgent deleveraging or dilutive financing.

Solid Gross Margin And Specialty Product PositioningA 21.1% gross margin reflects the presence of higher-value specialty products and functional materials that command specification-driven pricing. Sustained specialty mix supports margin resilience versus commoditized peers and underpins longer-term profitability if product qualification and customer relationships hold.

Bears Say

Negative Net Income And Profitability ErosionReported net losses erode retained earnings and constrain reinvestment. If negative net income persists over several quarters, it undermines ROE recovery, limits discretionary spending on R&D or capacity upgrades, and increases operational risk for sustaining specialty product programs.

Deteriorating Free Cash FlowWorsening negative free cash flow signals difficulty converting operations into cash. Persistently negative FCF reduces ability to fund capex, service debt, pay dividends or absorb raw material shocks without external funding, increasing structural financing risk over the medium term.

Weak Revenue TrendA declining top line suggests demand pressures or lost share in key segments. Even a modest downward trend, when paired with margin and cash issues, indicates structural challenges in market positioning, pricing power, or product mix that require strategic action to reverse over several months.

Denka Co News

Denka to Take Full Control of Toyo Styrene as Consolidated Subsidiary

The latest update is out from Denka Co ( ($JP:4061) ). Denka will acquire Daicel Corporation’s 15% stake...

11d ago

Denka Amends KAINOS Tender Offer Filing After Antitrust Clearance

The latest update is out from Denka Co ( ($JP:4061) ). Denka and its wholly owned subsidiary Flowers...

14d ago

Denka Weighs 2027 Spin-off of Styrene Business to Sharpen Portfolio

An update from Denka Co ( ($JP:4061) ) is now available. Denka has begun formally reviewing a potential...

21d ago

Denka Revamps Mission 2030 Plan to Rebuild Earnings and Enter New Growth Phase

Denka Co ( ($JP:4061) ) just unveiled an announcement. Denka has updated its Mission 2030 management plan with...

21d ago

Denka pivots “Mission 2030” to earnings rebuild with Phase 2 plan

Denka Co ( ($JP:4061) ) has issued an update. Denka has launched Phase 2 of its “Mission 2030”...

21d ago

Denka Sets Up Flowers Subsidiary for Joint Tender Offer for KAINOS Laboratories

Denka Co ( ($JP:4061) ) has shared an announcement. Denka has set up a wholly owned subsidiary, Flowers...

1M ago

Denka Books ¥14.2 Billion Extraordinary Loss on U.S. Elastomer Business Liquidation

An announcement from Denka Co ( ($JP:4061) ) is now available. Denka Company Limited will book an extraordinary...

1M ago

Denka Reshapes Executive Lineup and Roles to Strengthen Operations and Innovation

An announcement from Denka Co ( ($JP:4061) ) is now available. Denka Company Limited has announced a reshuffle...

1M ago

Denka Advances Shutdown and Cost Controls at U.S. Chloroprene Rubber Unit

Denka Co ( ($JP:4061) ) just unveiled an announcement. Denka reported on the ongoing suspension of production at...

1M ago

Denka Lifts Profit Outlook as Nine-Month Earnings Surge Despite Lower Sales

An announcement from Denka Co ( ($JP:4061) ) is now available. Denka reported consolidated net sales of ¥290.8...

1M ago

4061 FAQ

What was Denka Co Ltd’s price range in the past 12 months?

Denka Co Ltd lowest stock price was ¥1744.00 and its highest was ¥3750.00 in the past 12 months.

What is Denka Co Ltd’s market cap?

Denka Co Ltd’s market cap is ¥296.19B.

When is Denka Co Ltd’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Denka Co Ltd’s earnings last quarter?

Currently, no data Available

Is Denka Co Ltd overvalued?

According to Wall Street analysts Denka Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Denka Co Ltd pay dividends?

Denka Co Ltd pays a Semiannually dividend of ¥50 which represents an annual dividend yield of 3.71%. See more information on Denka Co Ltd dividends here

What is Denka Co Ltd’s EPS estimate?

Denka Co Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Denka Co Ltd have?

Denka Co Ltd has 88,555,840 shares outstanding.

What happened to Denka Co Ltd’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Denka Co Ltd?

Currently, no hedge funds are holding shares in JP:4061

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Denka Co Ltd

Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division supplies influenza vaccines; manufactures rapid diagnostic testing kits for detecting antigens of infectious diseases, such as the novel coronavirus; and delivers macromolecular sodium hyaluronate preparations. The company's Elastomers & Infrastructure Solutions division include functional elastomers, cement and special cement additives, fertilizers, agricultural corrugated pipes. Its Polymer Solutions division consist of styrene-based resins, food packaging sheets, and synthetic fiber for wigs and hairpieces, as well as poval and other chemical products. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Tokyo, Japan.